SRTA: financial statements from SEC — TradeAlmanac

SRTA

Strata Critical Medical, Inc.: financial statements

Company reports as filed with the U.S. Securities and Exchange Commission.

AnnualQuarterly

Income statement

Metric	Mar 31, 2026	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Sep 30, 2024	Jun 30, 2024
Revenue	67m	49m	71m	54m	36m	68m
Cost of revenue	53m	38m	53m	42m	29m	52m
Gross profit	14m	—	—	7m	—	—
Selling, general and administrative	16m	16m	20m	17m	14m	25m
Operating expenses	17m	55m	76m	62m	43m	80m
Operating income	−3m	−6m	−5m	−8m	−7m	−12m
Pre-tax income	2m	−10m	−4m	−4m	−6m	−11m
Income tax	0	0	21,000	−17,000	0	52,000
Net income	2m	57m	−4m	−3m	−2m	−11m
Earnings per share	0.03	0.70	−0.05	−0.04	−0.03	−0.15
Earnings per share, diluted	0.03	0.70	−0.05	−0.04	−0.03	−0.15
Weighted average shares	85m	82m	81m	80m	78m	78m
Weighted average shares, diluted	90m	82m	81m	80m	78m	78m

Balance sheet

Metric	Mar 31, 2026	Dec 31, 2025	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024
Cash and equivalents	59m	31m	23m	59m	35m	18m	20m	26m
Receivables	40m	40m	38m

Cash flow

Metric	Mar 31, 2026	Jun 30, 2025	Mar 31, 2025	Sep 30, 2024	Jun 30, 2024
Operating cash flow	4m	—	−246,000	—	—
Depreciation and amortisation	3m	2m	2m	1m	2m
Share-based compensation

Amounts in USD unless stated otherwise. Sources: Nasdaq Trader, Yahoo Finance, U.S. Securities and Exchange Commission (EDGAR)